1,215 research outputs found

    IgM-Associated Cryoglobulinaemia

    Get PDF
    Cryoglobulinaemia is characterised by serum immunoglobulins that precipitate at temperatures below 37 ◦C and redissolve on warming. Monoclonal IgM immunoglobulin can be associated with type I and II cryoglobulinaemia with underlying Waldenström macroglobulinemia, monoclonal gammopathy of undetermined significance, or another non-Hodgkin lymphoma. In this research, we review the clinical characteristics of monoclonal IgM-associated cryoglobulinaemia and suggest a management approach for addressing them. Laboratory testing is critical as even a minimal amount of measurable cryoglobulin may result in symptoms. Accurate detection of cryoglobulins may be challenging, care must be taken with preanalytical variables, and repeated testing of monoclonal protein and cryoglobulins is indicated if clinical suspicion is high. Presentations range from asymptomatic to showing multisystem involvement, meaning that careful evaluation of the features and a thorough interrogation of organ systems and the underlying clone are critical. Immediate management is required for clinical red-flag features. Due to their rarity, data to inform treatment decisions are scant and collaborative research is imperative must be conducted to aid researchers in efforts to define optimal treatment strategies

    Prevention and management of secondary central nervous system lymphoma

    Get PDF
    Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of relapse, and can be either isolated or with synchronous systemic disease. The risk of CNS involvement in patients with diffuse large B-cell lymphoma is approximately 5%; however, certain clinical and biological features have been associated with a risk of up to 15%. There has been growing interest in improving the definition of patients at increased risk of CNS relapse, as well as identifying effective prophylactic strategies to prevent it. SCNSL often occurs within months of the initial diagnosis of lymphoma, suggesting the presence of occult disease at diagnosis in many cases. The differing presentations of SCNSL create the therapeutic challenge of controlling both the systemic disease and the CNS disease, which uniquely requires agents that penetrate the blood-brain barrier. Outcomes are generally poor with a median overall survival of approximately 6 months in retrospective series, particularly in those patients presenting with SCNSL after prior therapy. Prospective studies of intensive chemotherapy regimens containing high-dose methotrexate, followed by hematopoietic stem cell transplantation have shown the most favorable outcomes, especially for patients receiving thiotepa-based conditioning regimens. However, a proportion of patients will not respond to induction therapies or will subsequently relapse, indicating the need for more effective treatment strategies. In this review we focus on the identification of high-risk patients, prophylactic strategies and recent treatment approaches for SCNSL. The incorporation of novel agents in immunochemotherapy deserves further study in prospective trials

    Application of artificial neural networks for understanding and diagnosing the state of mastitis in dairy cattle

    Get PDF
    Bovine mastitis adversely affects the dairy industry around the world. This disease is caused by a diverse range of bacteria, broadly categorised as minor and major pathogens. In-line tools that help identify these bacterial groupings in the early stages of the disease are advantageous as timely decisions could be made before the cow develops any clinical symptoms. The first objective of this research was to identify the most informative milk parameters for the detection of minor and major bacterial pathogens. The second objective of this research was to evaluate the potential of supervised and unsupervised neural network learning paradigms for the detection of minor infected and major infected quarters in the early stages of the disease. The third objective was to evaluate the effects of different proportions of infected to non-infected cases in the training data set on the correct classification rate of the supervised neural network models as there are proportionately more non-infected cases in a herd than infected cases. A database developed at Lincoln University was used to achieve the research objectives. Starting at calving, quarter milk samples were collected weekly from 112 cows for a period of fourteen weeks, resulting in 4852 samples with complete records for somatic cell count (SCC), electrical resistance, protein percentage, fat percentage, and bacteriological status. To account for the effects of the stage of lactation on milk parameters with respect to days in milking, data was divided into three days in milk ranges. In addition, cow variation was accounted for by the sire family from which the cow originated and the lactation number of each cow. Data was pre-processed before the application of advanced analytical techniques. Somatic cell score (SCS) and electrical resistance index were derived from somatic cell count and electrical resistance, respectively. After pre-processing, the data was divided into training and validation sets for the unsupervised neural network modelling experiment and, for the supervised neural network modelling experiments, the data was divided into training, calibration and validation sets. Prior to any modelling experiments, the data was analysed using statistical and multivariate visualisation techniques. Correlations (p<0.05) were found between the infection status of a quarter and its somatic cell score (SCS, 0.86), electrical resistance index (ERI, -0.59) and protein percentage (PP, 0.33). The multivariate parallel visualisation analysis validated the correlation analysis. Due to significant multicolinearity [Correlations: SCS and ERI (-0.65: p<0.05); SCS and PP (0.32: p<0.05); ERI and PP (-0.35: p<0.05)], the original variables were decorrelated using principle component analysis. SCS and ERI were found to be the most informative variables for discriminating between non-infected, minor infected and major infected cases. Unsupervised neural network (USNN) model was trained using the training data set which was extracted from the database, containing approximately equal number of randomly selected records for each bacteriological status [not infected (NI), infected with a major pathogen (MJI) and infected with a minor pathogen (MNI)]. The USNN model was validated with the remaining data using the four principle components, days in milk (DIM), lactation number (LN), sire number, and bacteriological status (BS). The specificity of the USNN model in correctly identifying non infected cases was 97%. Sensitivities for correctly detecting minor and major infections were 89% and 80%, respectively. The supervised neural network (SNN) models were trained, calibrated and validated with several sets of training, calibration and validation data, which were randomly extracted from the database in such a way that each set has a different proportion of infected to non-infected cases ranging from 1:1 to 1:10. The overall accuracy of these models based on validation data sets gradually increased with increase in the number of non-infected cases in the data sets (80% for the 1:1, 84% for 1:2, 86% for 1:4 and 93% for 1:10). Specificities of the best models for correctly recognising non-infected cases for the four data sets were 82% for 1:1, 91% for 1:2, 94% for 1:4 and 98% for 1:10. Sensitivities for correctly recognising minor infected cases for the four data sets were 86% for 1:1, 76% for 1:2, 71% for 1:4 and 44% for 1:10. Sensitivities for correctly recognising major infected cases for the four data sets were 20% for 1:1, 20% for 1:2, 30% for 1:4 and 40% for 1:10. Overall, sensitivity for the minor infected cases decreased while that of major infected cases increased with increase in the number non-infected cases in the training data set. Due to the very low prevalence of MJI category in this particular herd, results for this category may be inconclusive. This research suggests that somatic cell score and electrical resistance index of milk were the most effective variables for detecting the infection status of a quarter followed by milk protein and fat percentage. The neural network models were able to differentiate milk containing minor and major bacterial pathogens based on milk parameters associated with mastitis. It is concluded that the neural network models can be developed and incorporated into milking machines to provide an efficient and effective method for the diagnosis of mastitis

    Prevention and management of secondary central nervous system lymphoma

    Get PDF
    Prevention; LymphomaPrevenció; LimfomaPrevención; LinfomaSecondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of relapse, and can be either isolated or with synchronous systemic disease. The risk of CNS involvement in patients with diffuse large B-cell lymphoma is approximately 5%; however, certain clinical and biological features have been associated with a risk of up to 15%. There has been growing interest in improving the definition of patients at increased risk of CNS relapse, as well as identifying effective prophylactic strategies to prevent it. SCNSL often occurs within months of the initial diagnosis of lymphoma, suggesting the presence of occult disease at diagnosis in many cases. The differing presentations of SCNSL create the therapeutic challenge of controlling both the systemic disease and the CNS disease, which uniquely requires agents that penetrate the blood-brain barrier. Outcomes are generally poor with a median overall survival of approximately 6 months in retrospective series, particularly in those patients presenting with SCNSL after prior therapy. Prospective studies of intensive chemotherapy regimens containing high-dose methotrexate, followed by hematopoietic stem cell transplantation have shown the most favorable outcomes, especially for patients receiving thiotepa-based conditioning regimens. However, a proportion of patients will not respond to induction therapies or will subsequently relapse, indicating the need for more effective treatment strategies. In this review we focus on the identification of high-risk patients, prophylactic strategies and recent treatment approaches for SCNSL. The incorporation of novel agents in immunochemotherapy deserves further study in prospective trials

    Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy

    Get PDF
    We report a case of FLT3-mutated AML with t(6;9) in which induction chemotherapy with DA and midostaurin failed to achieve complete cytogenetic or molecular remission. Due to the COVID-19 pandemic and co-existing cellulitis, monotherapy with the selective FLT3-inhibitor gilteritinib was used as an alternative consolidation treatment option rather than further intensive chemotherapy. Gilteritinib was able to achieve complete molecular and cytogenetic remission despite the additional cytogenetic abnormality. This case provides supporting evidence for the use of single agent gilteritinib in high-risk primary refractory FLT3-mutated AML with t(6;9) prior to transplantation

    Expression of Growth Factors and Growth Factor Receptor in Non-healing and Healing Ischaemic Ulceration

    Get PDF
    AbstractObjectivesTo characterise the histological and cytokinetic characteristics of purely ischaemic ulcers and the processes that underpin healing following successful revascularisation.DesignProspective observational study.Materials and methodsBiopsies were taken immediately pre- and 6 weeks following successful revascularisation of solely ischaemic ulceration. They were evaluated for morphological differences using H&E staining for the platelet derived growth factor receptor (PDGFR), epidermal growth factor receptor (EGFR), TGFβreceptorIII (TGFβRIII), transforming growth factor beta 1 and 3 (TGFβ1 and TGFβ3) and von Willebrand factor (vWF) expression using immunohistochemistry. Localisation and quantification of these growth factors and receptors was assessed systematically by three independent investigators who were blinded to the timing of biopsy.ResultsPre-operatively, small vessel vasculitis, necrosis and infection with a profuse neutrophil and macrophage infiltrate was observed in all samples. Post-operative biopsies revealed a proliferation of new capillaries in and around the ulcer edge and base. vWF staining confirmed an endothelial layer within these new vessels. Following successful revascularisation there was less infection and inflammation with minimal vasculitis. These newly formed capillaries had increased staining for TGFβ3, PDGFR and TGFβRIII with staining for PDGFR also localised to dermal fibroblasts which were larger and more numerous. Accelerated epithelial cell proliferation was observed with detachment from the underlying dermis.ConclusionsHealing of purely ischaemic ulcers is characterised by vasculogenesis associated with increased presence of the proangiogenic cytokines PDGF and TGFβ3. These findings show promise for the use of growth factor manipulation to aid healing in ischaemic ulcers
    corecore